The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Parkinson's Disease Market Research Report 2025
Synopsis
The global Parkinson's Disease market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Parkinson's Disease is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Parkinson's Disease is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Parkinson's Disease in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Parkinson's Disease include Teva, Novartis, GSK, AbbVie, Merck, Boehringer Ingelheim, Amneal + Impax, Lundbeck and Sun Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Parkinson's Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Parkinson's Disease.
Report Scope
The Parkinson's Disease market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Parkinson's Disease market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Parkinson's Disease companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Teva
Novartis
GSK
AbbVie
Merck
Boehringer Ingelheim
Amneal + Impax
Lundbeck
Sun Pharma
Wockhardt
UCB
Bausch Health
Acadia
Segment by Type
Carbidopa/Levodopa
Dopamine Receptor Agonists
MAO-Inhibitors
Segment by Application
Hospitals
Clinics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Parkinson's Disease companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Parkinson's Disease market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Parkinson's Disease is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Parkinson's Disease is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Parkinson's Disease in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Parkinson's Disease include Teva, Novartis, GSK, AbbVie, Merck, Boehringer Ingelheim, Amneal + Impax, Lundbeck and Sun Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Parkinson's Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Parkinson's Disease.
Report Scope
The Parkinson's Disease market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Parkinson's Disease market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Parkinson's Disease companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Teva
Novartis
GSK
AbbVie
Merck
Boehringer Ingelheim
Amneal + Impax
Lundbeck
Sun Pharma
Wockhardt
UCB
Bausch Health
Acadia
Segment by Type
Carbidopa/Levodopa
Dopamine Receptor Agonists
MAO-Inhibitors
Segment by Application
Hospitals
Clinics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Parkinson's Disease companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Parkinson's Disease Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Carbidopa/Levodopa
1.2.3 Dopamine Receptor Agonists
1.2.4 MAO-Inhibitors
1.3 Market by Application
1.3.1 Global Parkinson's Disease Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Parkinson's Disease Market Perspective (2019-2030)
2.2 Parkinson's Disease Growth Trends by Region
2.2.1 Global Parkinson's Disease Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Parkinson's Disease Historic Market Size by Region (2019-2024)
2.2.3 Parkinson's Disease Forecasted Market Size by Region (2025-2030)
2.3 Parkinson's Disease Market Dynamics
2.3.1 Parkinson's Disease Industry Trends
2.3.2 Parkinson's Disease Market Drivers
2.3.3 Parkinson's Disease Market Challenges
2.3.4 Parkinson's Disease Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Parkinson's Disease Players by Revenue
3.1.1 Global Top Parkinson's Disease Players by Revenue (2019-2024)
3.1.2 Global Parkinson's Disease Revenue Market Share by Players (2019-2024)
3.2 Global Parkinson's Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Parkinson's Disease Revenue
3.4 Global Parkinson's Disease Market Concentration Ratio
3.4.1 Global Parkinson's Disease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Parkinson's Disease Revenue in 2023
3.5 Parkinson's Disease Key Players Head office and Area Served
3.6 Key Players Parkinson's Disease Product Solution and Service
3.7 Date of Enter into Parkinson's Disease Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Parkinson's Disease Breakdown Data by Type
4.1 Global Parkinson's Disease Historic Market Size by Type (2019-2024)
4.2 Global Parkinson's Disease Forecasted Market Size by Type (2025-2030)
5 Parkinson's Disease Breakdown Data by Application
5.1 Global Parkinson's Disease Historic Market Size by Application (2019-2024)
5.2 Global Parkinson's Disease Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Parkinson's Disease Market Size (2019-2030)
6.2 North America Parkinson's Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Parkinson's Disease Market Size by Country (2019-2024)
6.4 North America Parkinson's Disease Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Parkinson's Disease Market Size (2019-2030)
7.2 Europe Parkinson's Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Parkinson's Disease Market Size by Country (2019-2024)
7.4 Europe Parkinson's Disease Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Parkinson's Disease Market Size (2019-2030)
8.2 Asia-Pacific Parkinson's Disease Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Parkinson's Disease Market Size by Region (2019-2024)
8.4 Asia-Pacific Parkinson's Disease Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Parkinson's Disease Market Size (2019-2030)
9.2 Latin America Parkinson's Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Parkinson's Disease Market Size by Country (2019-2024)
9.4 Latin America Parkinson's Disease Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Parkinson's Disease Market Size (2019-2030)
10.2 Middle East & Africa Parkinson's Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Parkinson's Disease Market Size by Country (2019-2024)
10.4 Middle East & Africa Parkinson's Disease Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Teva
11.1.1 Teva Company Detail
11.1.2 Teva Business Overview
11.1.3 Teva Parkinson's Disease Introduction
11.1.4 Teva Revenue in Parkinson's Disease Business (2019-2024)
11.1.5 Teva Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Parkinson's Disease Introduction
11.2.4 Novartis Revenue in Parkinson's Disease Business (2019-2024)
11.2.5 Novartis Recent Development
11.3 GSK
11.3.1 GSK Company Detail
11.3.2 GSK Business Overview
11.3.3 GSK Parkinson's Disease Introduction
11.3.4 GSK Revenue in Parkinson's Disease Business (2019-2024)
11.3.5 GSK Recent Development
11.4 AbbVie
11.4.1 AbbVie Company Detail
11.4.2 AbbVie Business Overview
11.4.3 AbbVie Parkinson's Disease Introduction
11.4.4 AbbVie Revenue in Parkinson's Disease Business (2019-2024)
11.4.5 AbbVie Recent Development
11.5 Merck
11.5.1 Merck Company Detail
11.5.2 Merck Business Overview
11.5.3 Merck Parkinson's Disease Introduction
11.5.4 Merck Revenue in Parkinson's Disease Business (2019-2024)
11.5.5 Merck Recent Development
11.6 Boehringer Ingelheim
11.6.1 Boehringer Ingelheim Company Detail
11.6.2 Boehringer Ingelheim Business Overview
11.6.3 Boehringer Ingelheim Parkinson's Disease Introduction
11.6.4 Boehringer Ingelheim Revenue in Parkinson's Disease Business (2019-2024)
11.6.5 Boehringer Ingelheim Recent Development
11.7 Amneal + Impax
11.7.1 Amneal + Impax Company Detail
11.7.2 Amneal + Impax Business Overview
11.7.3 Amneal + Impax Parkinson's Disease Introduction
11.7.4 Amneal + Impax Revenue in Parkinson's Disease Business (2019-2024)
11.7.5 Amneal + Impax Recent Development
11.8 Lundbeck
11.8.1 Lundbeck Company Detail
11.8.2 Lundbeck Business Overview
11.8.3 Lundbeck Parkinson's Disease Introduction
11.8.4 Lundbeck Revenue in Parkinson's Disease Business (2019-2024)
11.8.5 Lundbeck Recent Development
11.9 Sun Pharma
11.9.1 Sun Pharma Company Detail
11.9.2 Sun Pharma Business Overview
11.9.3 Sun Pharma Parkinson's Disease Introduction
11.9.4 Sun Pharma Revenue in Parkinson's Disease Business (2019-2024)
11.9.5 Sun Pharma Recent Development
11.10 Wockhardt
11.10.1 Wockhardt Company Detail
11.10.2 Wockhardt Business Overview
11.10.3 Wockhardt Parkinson's Disease Introduction
11.10.4 Wockhardt Revenue in Parkinson's Disease Business (2019-2024)
11.10.5 Wockhardt Recent Development
11.11 UCB
11.11.1 UCB Company Detail
11.11.2 UCB Business Overview
11.11.3 UCB Parkinson's Disease Introduction
11.11.4 UCB Revenue in Parkinson's Disease Business (2019-2024)
11.11.5 UCB Recent Development
11.12 Bausch Health
11.12.1 Bausch Health Company Detail
11.12.2 Bausch Health Business Overview
11.12.3 Bausch Health Parkinson's Disease Introduction
11.12.4 Bausch Health Revenue in Parkinson's Disease Business (2019-2024)
11.12.5 Bausch Health Recent Development
11.13 Acadia
11.13.1 Acadia Company Detail
11.13.2 Acadia Business Overview
11.13.3 Acadia Parkinson's Disease Introduction
11.13.4 Acadia Revenue in Parkinson's Disease Business (2019-2024)
11.13.5 Acadia Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
